Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat

作者: D.H. Malin , W.D. Moon , P. Goyarzu , E. Barclay , N. Magallanes

DOI: 10.1016/J.LFS.2013.08.006

关键词: AntagonistNicotine withdrawalMonoamine oxidaseMonoamine oxidase BNicotinePharmacologyClorgylineSalineMonoamine oxidase AMedicine

摘要: Abstract Aims There have been many reports of monoamine oxidase (MAO) inhibition by non-nicotine ingredients in tobacco smoke, persisting for days after smoking cessation. This study determined the effect inhibiting MAO and its isoforms on nicotine withdrawal syndrome. Main methods Rats were rendered nicotine-dependent seven subcutaneous (s.c.) 9 mg/kg/day infusion bitartrate. Twenty-two hours termination infusion, they observed over 20 min somatically expressed signs. Three before observation, rats injected intraperitoneally (i.p.) with 4 mg/kg each A antagonist clorgyline B deprenyl, or saline alone. similar experiment was performed non-dependent, saline-infused rats. Another compared that received injections either further receiving deprenyl Key findings Combined treatment both inhibitors markedly significantly exacerbated signs infused rats, while having no significant effects s.c. alone had more than saline-injected deprenyl-injected fewer controls. Assays confirmed thoroughly reduced enzymatic activity activity. Significance The results suggest may contribute to intensity syndrome

参考文章(59)
B. Costall, B.J. Jones, M.E. Kelly, R.J. Naylor, E.S. Onaivi, M.B. Tyers, Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacology, Biochemistry and Behavior. ,vol. 36, pp. 339- 344 ,(1990) , 10.1016/0091-3057(90)90414-D
J. S. Fowler, N. D. Volkow, G.-J. Wang, N. Pappas, J. Logan, R. MacGregor, D. Alexoff, C. Shea, D. Schlyer, A. P. Wolf, D. Warner, I. Zezulkova, R. Cilento, Inhibition of monoamine oxidase B in the brains of smokers Nature. ,vol. 379, pp. 733- 736 ,(1996) , 10.1038/379733A0
Reinskje Talhout, Antoon Opperhuizen, Jan G.C. van Amsterdam, Role of acetaldehyde in tobacco smoke addiction European Neuropsychopharmacology. ,vol. 17, pp. 627- 636 ,(2007) , 10.1016/J.EURONEURO.2007.02.013
Robert H. Roth, Floyd E. Bloom, Jack R. Cooper, The Biochemical Basis of Neuropharmacology ,(1971)
K. Castagnoli, J. B. Petzer, S. J. Steyn, C. J. Van Der Schyf, N. Castagnoli, Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration. Inflammopharmacology. ,vol. 11, pp. 183- 188 ,(2003) , 10.1163/156856003765764353
Adrie W. Bruijnzeel, Mahendra Bishnoi, Irma A. van Tuijl, Kim F. M. Keijzers, Kate R. Yavarovich, Tim M. Pasek, Jenna Ford, Jon C. Alexander, Hidetaka Yamada, Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats Psychopharmacology. ,vol. 212, pp. 485- 499 ,(2010) , 10.1007/S00213-010-1970-0
Anne-Sophie Villégier, Lucas Salomon, Sylvie Granon, Jean-Pierre Changeux, James D Belluzzi, Frances M Leslie, Jean-Pol Tassin, Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to Nicotine Neuropsychopharmacology. ,vol. 31, pp. 1704- 1713 ,(2006) , 10.1038/SJ.NPP.1300987
Yiu K. Fung, Marian J. Schmid, Todd M. Anderson, Yuen-Sum Lau, Effects of nicotine withdrawal on central dopaminergic systems Pharmacology, Biochemistry and Behavior. ,vol. 53, pp. 635- 640 ,(1996) , 10.1016/0091-3057(95)02063-2
Magdalena Zaniewska, Andrew C. McCreary, Karolina Wydra, Małgorzata Filip, Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. Neuropharmacology. ,vol. 58, pp. 1140- 1146 ,(2010) , 10.1016/J.NEUROPHARM.2010.02.006